SBSP3
ONconsolidatedCIA SANEAMENTO BASICO EST SAO PAULO
CNPJ 43776517000180
—
Price step on 2026-04-29, consistent with a reverse split or split. High, low and change count from that day on — B3's file does not adjust the past, and mixing both steps would compare different share bases. The chart shows the raw series.
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Distributions
| Type | Approved on | Ex-date basis | R$ / share |
|---|---|---|---|
| JRS CAP PROPRIO | 2026-03-16 | 2026-03-19 | 0.833425 |
| JRS CAP PROPRIO | 2025-12-18 | 2025-12-23 | 2.643893 |
| DIVIDENDO | 2025-04-29 | 2025-04-29 | 1.051472 |
| JRS CAP PROPRIO | 2025-04-29 | 2025-04-29 | 2.679000 |
| JRS CAP PROPRIO | 2024-04-25 | 2024-04-25 | 1.440400 |
| JRS CAP PROPRIO | 2023-04-28 | 2023-04-28 | 1.276000 |
| JRS CAP PROPRIO | 2022-04-28 | 2022-04-28 | 0.942700 |
| JRS CAP PROPRIO | 2021-04-29 | 2021-04-29 | 0.397900 |
| JRS CAP PROPRIO | 2020-04-28 | 2020-04-28 | 1.376700 |
| JRS CAP PROPRIO | 2019-04-29 | 2019-04-29 | 1.159000 |
| JRS CAP PROPRIO | 2018-04-27 | 2018-04-27 | 1.029800 |
| JRS CAP PROPRIO | 2017-03-27 | 2017-04-10 | 1.204800 |
Gross amounts, by record date, from B3's registry — the Type column separates dividends, interest on equity and capital returns, and the 12-month yield adds all of them. A capital return is a refund, not income. Interest on equity (JCP) carries 15% withholding tax for individuals — the net yield is lower. Payment dates are not in this registry; they live in the shareholder notice.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 38.09bn | 8.46bn | 37.0% | 22.2% | 20.0% | 8.1% | 0.37 | 133.39 | — | 4.8% |
| 2024 | 36.15bn | 9.58bn | 54.1% | 26.5% | 25.9% | 11.8% | 0.45 | 88.50 | 6.31 | 1.6% |
| 2023 | 25.57bn | 3.52bn | 37.2% | 13.8% | 11.8% | 5.7% | 0.42 | 75.37 | 14.62 | 1.7% |
| 2012 | 10.75bn | 1.91bn | 39.9% | 17.8% | 16.3% | 7.2% | 0.40 | 86.87 | — | 2.9% |
| 2011 | 9.94bn | 1.22bn | 39.3% | 12.3% | 11.6% | 4.9% | 0.39 | 52.03 | 9.69 | — |
| 2010 | 9.23bn | 1.63bn | 43.7% | 17.7% | 16.8% | 7.0% | 0.40 | 42.59 | 5.95 | 5.1% |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
The table is entirely consolidated — the side that closes the most recent 12 months. The fiscal years 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022 exist only on the standalone side and are left out: mixing both sides in one column would compare figures of different natures.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 10.21bn | 3.17bn | 1.46bn | 14.3% |
| Q1 26 | 9.96bn | 3.38bn | 1.75bn | 17.6% |
| Q4 25 | 11.28bn | 3.88bn | 2.69bn | 23.8% |
| Q3 25 | 9.42bn | 2.53bn | 2.16bn | 22.9% |
| Q2 25 | 8.96bn | 3.35bn | 2.14bn | 23.8% |
| Q1 25 | 8.43bn | 2.84bn | 1.48bn | 17.6% |
| Q4 24 | 7.84bn | 1.77bn | 1.43bn | 18.3% |
| Q3 24 | 15.00bn | 9.86bn | 6.11bn | 40.8% |
| Q2 24 | 6.75bn | 2.22bn | 1.21bn | 17.9% |
| Q1 24 | 6.56bn | 1.66bn | 823.30m | 12.5% |
| Q4 23 | 7.27bn | 2.17bn | 1.19bn | 16.3% |
| Q3 23 | 6.45bn | 1.71bn | 846.30m | 13.1% |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 119.61bn | 45.31bn | 2.64 | 1.47 |
| Q1 26 | 116.72bn | 43.82bn | 2.66 | 1.74 |
| Q4 25 | 104.20bn | 42.40bn | 2.46 | 1.12 |
| Q3 25 | 95.99bn | 42.71bn | 2.25 | 1.17 |
| Q2 25 | 88.72bn | 40.44bn | 2.19 | 1.26 |
| Q1 25 | 85.69bn | 38.40bn | 2.23 | 1.09 |
| Q4 24 | 80.97bn | 36.93bn | 2.19 | 0.89 |
| Q3 24 | 76.13bn | 37.91bn | 2.01 | 1.14 |
| Q2 24 | 64.68bn | 31.80bn | 2.03 | 1.36 |
| Q1 24 | 65.05bn | 30.68bn | 2.12 | 1.23 |
| Q4 23 | 61.47bn | 29.86bn | 2.06 | 0.93 |
| Q3 23 | 59.05bn | 29.59bn | 2.00 | 1.00 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-12 | 43 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-07 | 37 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-03-16 | 75 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-10 | 41 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-11 | 42 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-12 | 42 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-03-24 | 83 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-11 | 42 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-08 | 39 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-05-09 | 39 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-03-21 | 81 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2023-11-09 | 40 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2023-08-10 | 41 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2023-05-11 | 41 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-03-23 | 82 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-10 | 41 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.